Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VieCell offers advanced regenerative medicine treatments using cell therapies, stem cells, exosomes, and cellular immunotherapies. They report positive patient outcomes in chronic diseases such as liver failure, cancer, autoimmune disorders, neurological conditions, and anti-aging. Their approach is multi-modal—combining cell therapies with microbiome correction and supportive care—and is positioned as an alternative or adjunct to conventional treatments for otherwise difficult-to-treat diseases. Patient testimonials indicate improvements in pain management, organ function recovery (notably liver), energy levels, blood pressure regulation, and overall quality of life. No peer-reviewed clinical trial data found.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VieCell Institute of Regenerative Medicine.